FindTrial
Sign In

determination of the minimum local analgesic concentration of epidural ropivacaine combined with or without sufentanil?for epidural labor analgesia in obese parturients

determination of the minimum local analgesic concentration of epidural ropivacaine combined with or without sufentanil for epidural labor analgesia in obese parturients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900023925
Enrollment
Unknown
Registered
2019-06-18
Start date
2019-07-01
Completion date
Unknown
Last updated
2019-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

labor analgesia

Interventions

normal parturients group 1:ropivacaine
obese parturients group 1:ropivacaine
normal parturients group 2:ropivacaine+sufentanil
obese parturients group 2:ropivacaine+sufentanil

Sponsors

Tianjin Central Hospital of gynecology and obstetrics
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. ASA grade I to II; 2. primipara with singleton pregnancies cephalic presentation; 3. gestational age greater than 37 weeks; 4. aged 20~45 years; 5. cervical dilatation is less than 3 cm at the time of epidural request; 6. VAS =40mm.

Exclusion criteria

Exclusion criteria: (1) contraindications for epidural anesthesia; (2) opioid or sedative medication before epidural placement; (3) a history of substance abuse; (4) history of cardiopulmonary disease or liver and kidney dysfunction; (5) neuropsychiatric disorders Historian; (6) allergic to research drugs; (7) non-reassuring fetal heart rate.

Design outcomes

Primary

MeasureTime frame
VAS;—

Secondary

MeasureTime frame
side effects;—

Countries

China

Contacts

Public ContactYanju Zhang

Tianjin Central Hospital of gynecology and obstetrics

565647027@qq.com+86 13502185615

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026